Sangamo Therapeutics, Inc. Stock
Stocks
SGMOQ
US8006771062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
15:54:24 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.1600 USD | +12.44% |
|
-4.93% | -61.90% |
| Market Cap | 66.29M 56.81M 53.14M 48.59M 91.69M 6.35B 92.66M 629M 245M 3.19B 249M 243M 10.55B | P/E 2024 |
-2.1x | P/E 2025 | -0.96x |
|---|---|---|---|---|---|
| Enterprise Value | 72.13M 61.82M 57.83M 52.87M 99.77M 6.91B 101M 684M 266M 3.47B 271M 265M 11.48B | EV / Sales 2024 |
3.49x | EV / Sales 2025 | 3.72x |
| Free-Float |
99.07% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Sangamo Therapeutics, Inc.
| 1 day | +12.44% | ||
| 1 week | -4.93% | ||
| Current month | +118.58% | ||
| 1 month | +146.15% | ||
| 3 months | -8.21% | ||
| 6 months | -66.14% | ||
| Current year | -61.90% |
| 1 week | 0.13 | 0.17 | |
| 1 month | 0.06 | 0.2 | |
| Current year | 0.03 | 0.6 | |
| 1 year | 0.03 | 0.77 | |
| 3 years | 0.03 | 3.18 | |
| 5 years | 0.03 | 11.49 | |
| 10 years | 0.03 | 27.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 63 | 2016-05-31 |
Nikunj Jain
DFI | Director of Finance/CFO | 47 | 2026-02-02 |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 2023-11-16 |
| Director | Title | Age | Since |
|---|---|---|---|
H. Parker
CHM | Chairman | 70 | 2017-05-31 |
Alexander Macrae
BRD | Director/Board Member | 63 | 2016-05-31 |
Robert Carey
BRD | Director/Board Member | 68 | 2016-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/24/26 | Tax | Executive/Senior Manager | 14,417 | 0.0043% | ||
| 2/24/26 | Tax | Chief Technology Officer | 5,951 | 0.0018% | ||
| 2/24/26 | Tax | Chief Executive Officer | 38,928 | 0.0116% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +12.44% | -4.93% | -72.71% | -81.82% | 58.95M | ||
| -4.31% | -6.62% | +65.79% | +98.02% | 72.12B | ||
| -4.19% | +1.05% | +52.79% | +85.53% | 65.85B | ||
| -3.22% | +23.17% | +1.75% | -5.23% | 29.28B | ||
| -1.42% | -3.38% | -5.99% | +465.34% | 27.47B | ||
| +4.32% | +4.26% | +52.19% | +14.21% | 26.7B | ||
| -1.81% | +0.38% | +34.52% | -18.33% | 20.06B | ||
| +5.36% | +4.61% | +270.18% | +415.10% | 18.22B | ||
| -0.57% | -3.78% | +11.11% | +517.39% | 16.4B | ||
| +0.87% | +4.26% | +41.21% | +150.80% | 13.4B | ||
| Average | +0.77% | +4.33% | +45.08% | +164.10% | 28.96B | |
| Weighted average by Cap. | -1.85% | +3.12% | +54.73% | +149.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 57.8M 49.53M 46.34M 42.37M 79.95M 5.53B 80.8M 548M 213M 2.78B 217M 212M 9.19B | 39.55M 33.9M 31.71M 28.99M 54.71M 3.79B 55.29M 375M 146M 1.9B 149M 145M 6.29B |
| Net income | -97.94M -83.94M -78.52M -71.79M -135M -9.38B -137M -929M -361M -4.71B -368M -360M -15.58B | -123M -105M -98.56M -90.11M -170M -11.77B -172M -1.17B -453M -5.91B -462M -452M -19.56B |
| Net Debt | -11.35M -9.73M -9.1M -8.32M -15.7M -1.09B -15.87M -108M -41.88M -546M -42.62M -41.7M -1.81B | 5.85M 5.01M 4.69M 4.29M 8.09M 560M 8.17M 55.47M 21.57M 281M 21.95M 21.48M 930M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | US$0.1600 | +12.44% | 2,706,299 |
| 26-08-21 | US$0.1423 | -11.17% | 5,486,587 |
| 26-08-20 | US$0.1602 | -0.50% | 1,704,868 |
| 26-08-19 | US$0.1610 | +0.94% | 1,994,671 |
| 26-08-18 | US$0.1595 | -5.23% | 3,868,733 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SGMOQ Stock
Select your edition
All financial news and data tailored to specific country editions

















